Search results for "Cough"
MKSAP Quiz: 3-day history of productive cough, sore throat
A 32-year-old man is evaluated for a 3-day history of productive cough, sore throat, coryza, rhinorrhea, nasal congestion, generalized myalgia, and fatigue. His sputum is slightly yellow. His two children (ages 3 years and 1 year) had similar symptoms 1 week ago. He is a nonsmoker and has no history of asthma. Following a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2014/09/09/3.htm
9 Sep 2014
New heart failure drug reduced hospitalization, death in trial
A new drug that combines a neprilysin inhibitor and an angiotensin-receptor blocker (ARB) reduced deaths and hospitalization for heart failure compared to an angiotensin-converting enzyme (ACE) inhibitor, an industry-funded study reported.
https://immattersacp.org/weekly/archives/2014/09/09/2.htm
9 Sep 2014
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Data drive debate over antivirals, theory vs. practice
Physicians should focus not only on influenza vaccinations but on treating patients who will get the disease whether they have been vaccinated or not.
https://immattersacp.org/archives/2014/10/antivirals.htm
1 Oct 2014
MKSAP Quiz: management of COPD
A 72-year-old woman is evaluated during a routine examination. She has very severe COPD with multiple exacerbations. She has dyspnea at all times with decreased exercise capacity. She does not have cough or any change in baseline sputum production. She is adherent to her medication regimen, and she completed pulmonary rehabilitation 1 year ago. She quit smoking 1 year ago. Her medications are a budesonide/formoterol inhaler, tiotropium, and an albuterol inhaler as needed. Following a physical and pulmonary exam, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2014/10/21/3.htm
21 Oct 2014
Incontinence can hide in middle age
Women may suffer debilitating quality-of-life issues from urinary incontinence yet never mention it to their primary care physicians. The condition can be successfully managed by nonsurgical and nonpharmacological means, if physicians can tactfully bring up the subject first.
https://immattersacp.org/archives/2015/02/incontinence.htm
1 Feb 2015
MKSAP Quiz: dyspnea in a patient with end-stage COPD
A 72-year-old man is evaluated for dyspnea at rest. He has end-stage COPD and is on a home hospice program. He has weight loss, reduced functional capacity, and muscle atrophy. His medications are ipratropium, salmeterol, fluticasone, albuterol as needed, and prednisone. He is uncomfortable, with chronic air hunger that has gradually increased over the past 2 weeks. Otherwise, his symptoms have been stable without change in cough, sputum production, or fever.
https://immattersacp.org/weekly/archives/2015/02/03/3.htm
3 Feb 2015
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
Improved BP control requires patients to change behavior
Physicians are working with patients on behavioral changes that might stave off the worst consequences of high blood pressure that occur later in life.
https://immattersacp.org/archives/2015/03/hypertension.htm
1 Mar 2015
Warnings on testosterone, new antibiotic approved
This update covers a label change on testosterone products clarifying that they are approved only for men who have low testosterone levels, as well as the approval of ceftazidime-avibactam (Avycaz) to treat complicated intra-abdominal infections.
https://immattersacp.org/archives/2015/05/fda.htm
1 May 2015